The aim of this investigation was to document hereditary breast cancer in Northern Ireland. Family history details from over nine hundred women were obtained by postal survey and one hundred and twenty nine home visits were carried out to collect pedigree information. The families documented varied in the number of affected women from three, which was the minimum criteria for inclusion, to a maximum of nine and many families described other features of hereditary disease such as bilateral breast cancer, ovarian and gastrointestinal malignancies.
INTRODUCTION
A family history of breast cancer is recognised as one of the most important risk factors for the disease.".2 In the majority of women breast cancer is due to a multifactorial combination of environmental and genetic factors. However breast cancer in some women is due to a major genetic influence. Several epidemiological" 2, 3 studies have suggested that an autosomal dominant gene may be present in approximately three per thousand individuals, and that this is responsible for a substantial proportion of the familial clustering of breast cancer in the population. It is now established that in some families the high incidence of breast cancer is due to a mutation in a gene, known as BRCA 1, which is located on the long arm of chromosome 17. 4 5 Hereditary breast cancer has a number of distinguishing features6 which include early age of onset of breast cancer, an autosomal dominant pattern of inheritance, an association with other malignancies, an excess of bilateral disease and a better prognosis. It was decided to undertake a study to document hereditary breast cancer families within the community.
METHODS
Suitable families were identified by selecting pre-menopausal women who had developed breast cancer. In addition, specialist breast clinics, a charity cancer screening organisation and general practitioners were involved in identifying families containing at least three women who had developed breast cancer. In addition appropriate surveillance requires a specialist breast surgeon, with the availability of both cytopathology and radiology breast imaging services. Apart from families who were identified either through attendance at specialist breast clinics or 'Action Cancer' breast screening we found little evidence that breast cancer-prone women attend for genetic assessment or screening investigation. When the possibility was discussed, usually when obtaining a pedigree, many women expressed an interest in attending a breast cancer family clinic but at present this type of service is unavailable in Northern Ireland. This study shows that families and women can be identified in the Northern Ireland community who are at risk of developing breast cancer and who may benefit from such a clinic.
